Mesa Laboratories, Inc. MLAB
NASDAQ · United States · Health Technology
$133.75+4.45 (+3.44%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Moby summary of Mesa Laboratories, Inc.'s Q1 2027 earnings call
Adjusted operating income surges nearly 20% as the company returns to core organic growth and strengthens its balance sheet.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.